NCT07128303

Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors

RecruitingPHASE1INTERVENTIONAL

Trial Details

Start: 2025-08-28Est. Completion: 2028-05

Enrollment target: 476 participants

Locations

Massachusetts General Hospital, Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
START New Jersey, New Brunswick, New Jersey, United States
START San Antonio, San Antonio, Texas, United States
NEXT Virginia, Fairfax, Virginia, United States
Yonsei University Severance Hospital, Seoul, South Korea
Seoul National University Hospital, Seoul, South Korea
Asan Medical Center, Seoul, South Korea
Samsung Medical Center, Seoul, South Korea
Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
START Madrid - FJD - Hospital Fundación Jiménez Díaz - Phase I Clinical Trials Unit, Madrid, Spain
START - Centro Oncológico Clara Campal, Madrid, Spain

Contact

Gilead Clinical Study Information Center

Other microbiome trials you might be interested in

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)Phase 3Recruiting

Carcinoma, Non-Small-Cell Lung

This is a trial to evaluate the efficacy, safety, and tolerability of adagrasib plus pembrolizumab plus platinum-doublet…

Birmingham, United StatesEst. completion Sep 7, 2029

View Trial →

DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine CancersPhase 1Recruiting

Small Cell Lung CancerLarge Cell Neuroendocrine Lung CarcinomaExtrapulmonary Neuroendocrine Carcinoma of Small Cell HistologyExtrapulmonary Neuroendocrine Carcinoma of Large Cell Histology

This study is open to adults with advanced small cell lung cancer and other neuroendocrine cancers. The study has 2 part…

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.